Phibro Animal Health (NASDAQ:PAHC) Issues Earnings Results, Beats Expectations By $0.01 EPS

Phibro Animal Health (NASDAQ:PAHC) announced its quarterly earnings data on Wednesday. The company reported $0.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.78 by $0.01, FiscalAI reports. Phibro Animal Health had a net margin of 6.66% and a return on equity of 37.32%. The business had revenue of $386.77 million during the quarter, compared to the consensus estimate of $382.42 million.

Phibro Animal Health Trading Down 6.5%

PAHC stock traded down $2.30 during trading on Friday, hitting $33.10. The company had a trading volume of 208,475 shares, compared to its average volume of 281,741. Phibro Animal Health has a 52-week low of $28.25 and a 52-week high of $60.08. The company has a 50 day simple moving average of $37.14 and a 200-day simple moving average of $41.07. The firm has a market capitalization of $1.34 billion, a P/E ratio of 13.19 and a beta of 0.42. The company has a quick ratio of 1.27, a current ratio of 2.96 and a debt-to-equity ratio of 1.84.

Phibro Animal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 16th. Investors of record on Wednesday, November 25th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 1.5%. The ex-dividend date of this dividend is Wednesday, November 25th. Phibro Animal Health’s dividend payout ratio (DPR) is currently 19.67%.

Analyst Upgrades and Downgrades

PAHC has been the topic of a number of analyst reports. Zacks Research raised Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Friday, September 18th. Weiss Ratings raised Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, Phibro Animal Health currently has an average rating of “Buy” and a consensus price target of $47.67.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.